Pfizer
1849
FOUNDED
PUBLIC
STATUS
90K-95K
EMPLOYEES
PFE
STOCK SYMBOL
87
INVESTMENTS
$38.22
SHARE PRICE
(As of Wednesday Closing)
Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales.
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Drug Discovery
Stock Exchange
NYS
Primary Office
- 235 East 42nd Street
- New York, NY 10017
- United States
+1 (212) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Pfizer’s full profile, request a free trial.
Pfizer Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $33.97 - $44.90 | $212B | $38.48 | $2.91 | 18.7M | 5.53B |
Pfizer Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 232,867,567 | 283,866,715 | 243,284,819 | 227,118,175 |
| Revenue | 53,039,000 | 53,647,000 | 52,546,000 | 52,824,000 |
| EBITDA | 25,761,000 | 19,252,000 | 19,453,000 | 14,824,000 |
| Net Income | 16,216,000 | 11,153,000 | 21,308,000 | 7,215,000 |
| Total Assets | 170,446,000 | 159,422,000 | 171,797,000 | 171,615,000 |
| Total Debt | 52,661,000 | 41,740,000 | 43,492,000 | 42,085,000 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Pfizer Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Pfizer‘s full profile, request access.
Request full access to PitchBookPfizer Competitors (44)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merck & Co. | Corporation | Kenilworth, NJ | 00000 | |||
| 0000000 & 0000000 | Corporation | New Brunswick, NJ | 000000 | 0000 | ||
| 000000 | Formerly VC-backed | Cambridge, MA | 0000 | 000.00 | 00000000000 | 000.00 |
| 0000 0000000000000 | Corporate Backed or Acquired | Petach Tikva, Israel | 00000 | 00000 | 00000000000 | 00000 |
| 00000000000 | Formerly PE-Backed | Cambridge, United Kingdom | 00000 | 000 | 00000000 | 000 |
Pfizer Investments & Acquisitions (87)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 01-Aug-2019 | 00000 0000000 | Pharmaceuticals | 000 0000 | |
| 00000 000000000 | 30-Jul-2019 | 000000000000000000 | 000.00 | Biotechnology | 000000 000000 00.0 |
| 00000 | 29-Jul-2019 | 000000000000000000 | 0000 | Pharmaceuticals | 000000 000000 00.0 |
| 000000000 | 01-Jul-2019 | 000000000000000000 | 00000 | Drug Discovery | 000000 0000000 00.0 |
| GlaxoSmithKline (Consumer Healthcare Business) | 24-May-2019 | Secondary Transaction - Private | Other Healthcare Services |
Pfizer Exits (22)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 | 04-Jan-2019 | 000000000 | 00000 | Completed |
|
| 0000000 0000000000 | 01-Nov-2017 | 000000000 | 00000 | Completed |
|
| 00 000000 00000000 | 13-Dec-2016 | 000000000 | Completed |
|
|
| 00000000 000000000 | 04-Aug-2016 | 000 | 0000 | Completed |
|
| Gemphire Therapeutics | 09-Mar-2016 | Early Stage VC | 000.00 | Completed |
|
Pfizer Subsidiaries (22)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Bamboo Therapeutics | Biotechnology | Chapel Hill, NC | 2014 |
| 0000000000 | Pharmaceuticals | Piscataway Township, NJ | 0000 |
| 0000000 000(0) 000 | Corporate Pension | Peapack, NJ | 0000 |
| 0000000 | Medical Supplies | Lake Forest, IL | 0000 |
| 000000 00000000 | Corporate Venture Capital | New York, NY | 0000 |
Pfizer Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Pfizer‘s full profile, request access.
Request full access to PitchBookPfizer Executive Team (314)
82 Former Executives
You’re viewing 5 of 314 executives. Get the full list »Pfizer Board Members (16)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 000000 000000 00.0 | Pfizer | Chief Executive Officer & Board Member | 000 0000 | |
| 00000 0000000 | Pfizer | Director, Portfolio Director & Planning Lead, PMP, Pfizer Oncology | 000 0000 | |
| 000000 00000000 00 | Pfizer | Board Member | 000 0000 | |
| 00000 00000 | Pfizer | Board Member | 000 0000 | |
| 000 0000 | Pfizer | Chairman & Board Member | 000 0000 |
5 Former Board Members
You’re viewing 5 of 16 board members. Get the full list »